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Synthetic mRNAs were produced using either the complete coding sequence of a human preproendothelin-1 cDNA clone or a truncated form 
in which the portion encoding the first 17 amino acids, representing a putative signal peptide for insertion into the endoplasmic reticulum, was 
replaced with a methionine codon. The mRNAs were translated in vitro in the presence or in the absence of microsomal membranes. Protection 
from trypsin digestion demonstrated that the full-length polypeptide, but not the truncated form, could be inserted into the membranes. Sequence 
analysis revealed that membrane insertion is accompanied by removal of the first 17 amino acids. These results indicate that the first 17 amino 
acids of human preproendothelin-1 are a functional signal peptide which allows the protein to enter the secretory pathway. 
Endothelin biosynthesis; Endoplasmic reticulum; Signal peptide 
1. INTRODUCTION 
The in vivo biosynthetic pathway of the 21 amino 
acid peptide endothelin (ET), one of the most potent 
vasoconstrictors known, is not yet completely clarified 
[ 11. The primary translation product, as deduced by se- 
quencing of cDNAs of different mammalian sources 
[2,3], is a polypeptide of around 200 amino acids. Ex- 
pression of a cDNA clone in E. cali resulted in the syn- 
thesis of a polypeptide with approximately the expected 
size of the primary translation product [4]. However, 
this precursor has never been identified in the native 
cells. The largest precursor of ET-l so far identified in 
vivo is big ET-l, which differs from ET-I in having an 
extension of I7 or 18 amino acids at the carboxy ter- 
minus [5,6]. The cleavage point for the conversion of 
big ET-l into ET-l is between Trp and Val, at an 
unusual processing site, while big ET-1 probably 
originates from endoproteolytic cleavage at paired basic 
residues [2]. The first 19 amino acids of the porcine 
precursor [2] and the first 17 amino acids of the human 
precursor [3] show the sequence characteristics of a 
signal peptide for the insertion into the endoplasmic 
reticulum (ER), as predicted by the algorithm of Von 
Heijne [7]. The precursor has therefore been termed 
preproET-1 [2]. The fact that big ET-l and ET-1 were 
found in the cell culture media, and the presence of a 
putative signal peptide, suggest hat processing steps 
may occur during protein transport hrough the ER- 
mediated secretory pathway or immediately after secrc- 
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tion. However, some proteins that do not carry a func- 
tional signal peptide may follow an alternative secretory 
mechanism, not ER-mediated [SJ. In a first effort to 
elucidate the pathway of ET-1 synthesis and the 
subcellular organelles involved in the processing steps, 
we show here that the first 17 amino acids of 
prepPoET- indeed function as a signal peptide. 
2. MATERIALS AND METHODS 
2.1. Construcrion of plastnids, transcriplion and translation 
The cDNA encoding preproET-I was isolated from a human 
placenta polyA+ library as previously described [PI. To remove the 5’ 
untranslated sequence, the 1.1 kb EcoRl fragment of 
M13mpl&ET(A) was amplified with the polymerase chain reaction 
using two specific oligonucleotides with StnaI linkers. The sense- 
orientation oligonucleotide (5 ‘-GTCACTCCCGGGAGAATGGA- 
TTATTTGCTCATG-3’) begins at -3 of the coding strand whereas 
the antisense-orientation oligonucleotide (S’-GTCACTCCCGGGG- 
ATCCGAATGAGACTGTGTGTTTCTGCT-3’) complements the 
sequence starting from the end of the cDNA. The Steal-digested frag- 
ment, after being controlled by sequencing, was subcloned into blunt- 
ended dephosphorylated &/II site of the plasmid pSP64T [IO]. This 
expression plasmid was termed CNRl. To produce CNR2, the same 
strategy was used but a different sense-orientation oligonucleotide 
was synthesized (5’-GTCACTCCCGGGAGAATGGCTCCAGAA- 
ACAGCAGTCTTAGG-3’). In this way the codons encoding the first 
17 amino acids in preproET-I were replaced by one ATG. We used 
the PC/GENE PSIGNAL program to determine the potential 
cleavage site of the prescquence, 
In vitro transcription and trdnslation in the presence of L- 
[4,5-“Hlleucinc (5.62 TBq/mmol, Amersham international) were 
essentially as described by Fabbrini et al. [I I], except that SPG RNA 
polymcrase (Pi-omega Biotec, Madison) was used, at 0.6 U/PI final 
concentration. In vitro translation in the presence of microsomal 
membranes was performed as specified by the manufacturer (Pro- 
mega Biotcc, Madison). 
2.2. Trjpsin Ircalrttettf 
Trnnrcriptsof CNRI or CNR2 were translated in a final volume of 
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30 ~1 in the presence or in the absence of microsomal membranes. At 
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the end of the translation CaCl2 in 20 mM HEPES, pH 7.5, was ad- 
ded to a 1.66 mM final concentration. Each sample was then in- 
cubated for 10 min on ice. Aliquots of It pl were made up to 15.5 111 
with water or Triton X-100 (1% final) in the presence or absence of 
50 pg/ml freshly prepared trypsin (Sigma, St. Louis). After incuba- 
tion for 30 min on ice, 0.5 pg of soybean trypsin inhibitor (Boehr- 
inger, Mannheim) were added. After IO additional min on ice, 
samples were analyzed by SDS-PAGE and fluorography. 
CNRI, as also suggested by the smeared pattern of the 
CNRl product. 
2 -3. Nl+terminal sequence analysis 
For protein sequence analysis, the CNRl transcript was translated 
in the presence of microsomal membranes and labeled with [‘H]Leu 
in a final volume of 150al or with L-[2,3,4,5-3H]proline 
(3.48 T&q/mmol, Amersham International) in a final volume of 
30,~l. Samples were then treated with trypsin as described above. 
After SDS-PAGE, protein samples were electroblotted onto 
polyvinylidene difluoride membranes (lmmobilon P. Millipore, Bed- 
ford) at 300 mA for 45 min using IO mM 3.(cyclohexylamino)-l- 
propanesulfonic acid, pH 1 I, 10% methanol as transfer buffer. The 
radiolabelled bands were excised from the membrane and arranged in 
the cartridge block of the sequencer, beneath a polybrene- 
preconditioned trifluoroacetic acid-treated glass-fiber filter [12]. 
Automated Edman degradation was performed on a Gas-Phase Se- 
quencer Model 470A (Applied Biosystems, Foster City) using the 
manufacturer’s program ATZ470-1. The radioactivity in each cycle 
fraction was determined by scintillation counting. 
3. RESULTS AND DISCUSSION 
The complete coding sequence of human preproET-1 
was subcloned into the expression vector pSP64T [lo]. 
The construct was termed CNRI (Fig. 1). In a second 
construct (termed CNRZ), the nucleotides encoding the 
first 17 amino acids, representing a putative signal se- 
quence for insertion into the ER, were removed and 
replaced by the translation initiator codon ATG 
(Fig, 1). Synthetic RNAs were produced by in vitro 
transcription and then tested in the reticulocyte lysate 
translation system supplemented with [‘Hlleucine 
(Fig. 2). The polypeptide synthesized by the CNRl 
transcript had an apparent M, around 23000, although 
the band was somehow smeared (lane 4 or 6). This is in 
good agreement with the expected size of preproET-1. 
Putative proET-1, synthesized upon translation of 
CNRZ, behaved as a more defined band with slightly 
lower electrophoretic mobility on SDS-PAGE, instead 
of the expected higher mobility (lane S), This may be 
due to abnormal SDS binding of the presequence in 
Fig. I. Schctnatic reprcscntntlQn of the conatrum CNRI and CNRZ. 
Deshcd box, putative signal pcptide; bluck box, mature ET-1 a A~~rlna 
acids are indicated using Ike owlcttcr code. 
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To test whether the first 17 amino acids of 
preproET-1 direct the insertion of the polypeptide into 
the ER, translation of the CNRl transcript was per- 
formed in the presence of pancreatic canine 
microsomes. Under these conditions, CNRl syn- 
thesized a major polypeptide which co-migrated with 
the product of CNR2 translated in the absence of mem- 
branes (Fig. 2, compare lane 3 with lane 5 and Fig. 3, 
compare lane 6 with lane 9). Conversely, the mobility of 
CNR2 product was not affected by the presence of 
membranes (Fig. 3, compare lane 1 with lane 2). These 
results strongly suggested that a large portion of 
preproET-1 underwent removal of its presequence in 
the presence of membranes. To determine whether 
CNRl produst was translocated into microsomes, we 
performed an assay of protection against tryptic diges- 
tion (Fig. 3). In the presence of membranes only the 
product of CNRl (lanes 6 and 7), but not that of CNR2 
(lanes 2 and 3), was partially resistant to trypsin. The 
protected form was that co-migrating with the CNR2 
product (compare lanes 6 and 7 and lanes 9 and 10). 
Resistance was not intrinsic, since it could be abolished 
by Triton X-100 treatment (lane 8). Together these 
- 46 
- 14 
123456 
Fig. 2, In vitro trttnslation of CNRI md CNK2 tranrcripts with or 
without niicrosomal mcmbruncs. Annlpnis of the polppcptidcs ws by 
SDS-PACE nnd fluorogrephy. bttncs I ttnd 2: nt~ RNA, 9% controls. 
Poritiona al molecular ~UXX markers (in kDrr) we indicated on the 
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Fig. 3. Trypsin treatment of polypeptides synthesized in vitro by 
CNRI and CNR2 transcripts. Analysis was by SDS-PAGE and 
fluorography. Positions of molecular mass markers (in kDa) are 
indicated on the right. 
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Cycle number 
results indicate that the presequence directs insertion of 
preproET-1 into the microsomes. 
Finally, we determined the positions of the first’ 
Ieucine and of the first proline present in the membrane- 
inserted CNRl translation product. The CNRl 
transcript was translated in the presence of microsomal 
membranes and either [3H]Leu or [3H]Pro. Samples 
were then treated with trypsin and, after enzyme inac- 
tivation, run on SDS-PAGE. The gel was then blotted 
onto a polyvinylidene difluoride membrane, the 
radiolabelled bands were excised, and protein subjected 
to automated Edman degradation. The potential 
cleavage site between position 17 and 18 conforms to 
the (-3, -1) rule of Von Heijne [7] and the highest score 
(9.18) is found at this position. As expected for cleavage 
at this site, the first [3HJ[eucine appeared at the seventh 
cycle of Edman degradation, while the first [3H]proline 
was removed at the second cycle (Fig. 4). This clearly 
indicates that upon insertion into microsomes the first 
17 amino acids of preproET-I had been removed. 
In conclusion, we determined that the first step in the 
synthesis of human ET-l consists of insertion into the 
ER. Insertion is mediated by a signal peptide of 17 
amino acids, which is then removed. Most probabIy, in 
vivo proET-1 is then transported along the secretory 
pathway through the Golgi complex. At which posi- 
tions along the pathway subsequent processing steps oc- 
cur remains to be elucidated. 
Cycle number 
ET ASP RR LEU LEU MT ILE PHE SER LEU LEU 
PHE VAL ALA CYS GLN GLY 
ALA VAL 1% 0I.Y ALA 
Fig. 4, Ni+terminal rcqucrm amlysls of the polypc~>ridr synthestzcd in vitro by CNRI transcript ;~nd inscrtcd into microromet me~nbranes. The 
graph at the left show5 rtic recovery of [3H]leucine in cacli sequewx cycle, The graph at the riglIt shows fhc recovery of [9-t]protitic in each 
sequencer cycle. Arrow ill the acquencc at the bottom indicaka ttic deduced splicing skc of prepro ET-I. 
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